tobacco

Prices for certain sweetened liquid nicotine products have jumped since the FDA has begun cracking down on sales to underage teens.
Marijuana trends showing higher use after cannabis legalization in Canada.
The U.S. Food and Drug Administration has authorized Philip Morris's IQOS heated-tobacco device and tobacco products for sale in the United States. The devices are now available in 45 countries...
Marlboro cigarette maker Altria missed first-quarter profit and revenue estimates.
Merrill Lynch has started coverage of the legalized cannabis industry with a mostly positive view, indicating that pullbacks in these names could create attractive entry points for new investors.
The FDA has issued a safety alert related to the use of e-cigarettes, especially among young Americans. The agency has received a number of reports that mentioned seizures having occurred while...
Eleven states have passed legislation raising the legal age for purchases of tobacco and electronic cigarette products to 21.
The ability to market tobacco has been challenged by one of the world's largest health organizations. If the plan works, billions of dollars in tobacco ads could disappear.
Around 4.9 million middle and high school students used tobacco in 2018. That is up from 3.6 million in 2017, a 36% increase. Virtually the entire increase was due to e-cigarette use.The Centers for...
It is supposed to be undeniable that smoking and using any forms of tobacco is bad for your health. And the rate of smoking cigarettes has been on the decline for years and years now. That said, a...
Calling Walgreen's the worst-performer among pharmacies when it comes to selling tobacco products to minors, the FDA this week filed a complaint to ban sales of tobacco products in one of the...
Marijuana producer Canopy Growth is on a buying spree. The company announced an investment of C$30 million in a Canadian producer and plans on investing as much as $500 million more.
Altria is entering a new partnership with Lexaria Nicotine to fund the research and development of Lexaria’s patented DehydraTECH technology.
Tilray shares are back under $100, and a routine IPO lock-up expiration has removed almost 10% of the value of its shares in just one day.
Diversification is supposed to be a good thing. But at what price is another issue entirely, as seen in Altria on Thursday.